Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 73951 - 73975 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silver	Approved Investigational	MIR155	406947	upregulated	Silver results in increased expression of MIR155 mRNA	21q21.3	A24216
Silver	Approved Investigational	MIR15A	406948	downregulated	Silver analog results in decreased expression of MIR15A mRNA	13q14.2	A24215
Silver	Approved Investigational	MIR16-1	406950	downregulated	Silver analog results in decreased expression of MIR16-1 mRNA	13q14.2	A24215
Silver	Approved Investigational	MIR181C	406957	downregulated	Silver analog results in decreased expression of MIR181C mRNA	19p13.12	A24215
Silver	Approved Investigational	MIR187	406963	downregulated	Silver results in decreased expression of MIR187 mRNA	18q12.2	A24216
Silver	Approved Investigational	MIR18A	406953	downregulated	Silver results in decreased expression of MIR18A mRNA	13q31.3	A24216
Silver	Approved Investigational	MIR18B	574033	downregulated	Silver analog results in decreased expression of MIR18B mRNA	Xq26.2	A24215
Silver	Approved Investigational	MIR18B	574033	downregulated	Silver results in decreased expression of MIR18B mRNA	Xq26.2	A24216
Silver	Approved Investigational	MIR191	406966	downregulated	Silver results in decreased expression of MIR191 mRNA	3p21.31	A24216
Silver	Approved Investigational	MIR192	406967	upregulated	Silver results in increased expression of MIR192 mRNA	11q13.1	A24216
Silver	Approved Investigational	MIR196B	442920	downregulated	Silver results in decreased expression of MIR196B mRNA	7p15.2	A24216
Silver	Approved Investigational	MIR198	406975	downregulated	Silver results in decreased expression of MIR198 mRNA	3q13.33	A24216
Silver	Approved Investigational	MIR19A	406979	downregulated	Silver analog results in decreased expression of MIR19A mRNA	13q31.3	A24215
Silver	Approved Investigational	MIR19A	406979	upregulated	Silver results in increased expression of MIR19A mRNA	13q31.3	A24215
Silver	Approved Investigational	MIR19B2	406981	upregulated	Silver results in increased expression of MIR19B2 mRNA	Xq26.2	A24215
Silver	Approved Investigational	MIR200A	406983	upregulated	Silver results in increased expression of MIR200A mRNA	1p36.33	A24216
Silver	Approved Investigational	MIR200C	406985	upregulated	Silver results in increased expression of MIR200C mRNA	12p13.31	A24216
Silver	Approved Investigational	MIR20B	574032	downregulated	Silver results in decreased expression of MIR20B mRNA	Xq26.2	A24216
Silver	Approved Investigational	MIR214	406996	upregulated	Silver analog results in increased expression of MIR214 mRNA	1q24.3	A24215
Silver	Approved Investigational	MIR22	407004	upregulated	Silver results in increased expression of MIR22 mRNA	17p13.3	A24216
Silver	Approved Investigational	MIR23A	407010	upregulated	Silver analog results in increased expression of MIR23A mRNA	19p13.12	A24215
Silver	Approved Investigational	MIR23B	407011	upregulated	Silver analog results in increased expression of MIR23B mRNA	9q22.32	A24215
Silver	Approved Investigational	MIR23B	407011	upregulated	Silver results in increased expression of MIR23B mRNA	9q22.32	A24215
Silver	Approved Investigational	MIR27A	407018	upregulated	Silver results in increased expression of MIR27A mRNA	19p13.12	A24216
Silver	Approved Investigational	MIR27B	407019	downregulated	Silver results in decreased expression of MIR27B mRNA	9q22.32	A24216

Displaying entries 73951 - 73975 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability